Evidence map›Paper›PMID 32033850›Full record

ArticleVaccine2020

Trivalent inactivated influenza vaccine (IIV3) during pregnancy and six-month infant development.

Lyndsay A Avalos, Jeannette Ferber, Ousseny Zerbo, Allison L Naleway, Joanna Bulkley, Mark Thompson, Janet Cragan, Jennifer Williams, Roxana Odouli, Tia L Kauffman and 3 more

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Lyndsay A AvalosDivision of Research, Kaiser Permanente Northern California, Oakland, CA, United States. Electronic address: Lyndsay.A.Avalos@kp.org.
Jeannette FerberDivision of Research, Kaiser Permanente Northern California, Oakland, CA, United States.
Ousseny ZerboDivision of Research, Kaiser Permanente Northern California, Oakland, CA, United States.
Allison L NalewayCenter for Health Research, Kaiser Permanente Northwest, Portland, OR, United States.
Joanna BulkleyCenter for Health Research, Kaiser Permanente Northwest, Portland, OR, United States.
Mark ThompsonInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Janet CraganNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
Jennifer WilliamsNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
Roxana OdouliDivision of Research, Kaiser Permanente Northern California, Oakland, CA, United States.
Tia L KauffmanCenter for Health Research, Kaiser Permanente Northwest, Portland, OR, United States.
Sarah BallAbt Associates, Cambridge, MA, United States.
Pat ShifflettAbt Associates, Cambridge, MA, United States.
De-Kun LiDivision of Research, Kaiser Permanente Northern California, Oakland, CA, United States.
Kaiser Permanente · USCenters for Disease Control and Prevention · USKaiser Permanente Center for Health Research · USAbt Global (United States) · US

Funding

The Impact of Folate, Obesity and Genetics on Maternal DepressionK01MH103444 · NIMH · KAISER FOUNDATION RESEARCH INSTITUTE · PI AVALOS, LYNDSAY AMMON · 2014 to 2016
$615k
Intramural CDC HHS CC999999NIMH NIH HHS K01 MH103444
6 · The paper itself

Abstract

objectiveDespite recommendations by professional organizations that all pregnant women receive inactivated influenza vaccine, safety concerns remain a barrier. Our objective was to assess the effect of trivalent influenza vaccines (IIV3) during pregnancy on parent report 6-month infant development.

methodsWe conducted a multi-site prospective birth cohort study during the 2010-2011 influenza season and followed pregnant women and their newborns through 6 months of age. Information on IIV3 during pregnancy was ascertained from the EHR and self-report. The Ages and Stages Questionnaire-3 (ASQ-3) was completed by the mother to assess 6-month infant neurodevelopment in five domains (communication, gross motor, fine motor, problem-solving, and personal adaptive skills). Scores for each domain above the cut-off point indicating typical development were categorized as "on schedule" while scores in the zones indicating the need for either monitoring or further assessment were categorized as "not on schedule". Multivariable logistic regression was conducted.

resultsOf the 1225 infant-mother pairs, 65% received IIV3 during pregnancy. In bivariate analysis, infants of women who received IIV3 during pregnancy were moderately-less likely to need monitoring or further assessment in the personal social domain compared with infants of unvaccinated women (10.0% vs. 14.1%, p = 0.033; crude OR (cOR): 0.68(95%CI:0.48,0.97)). However, after controlling for potential confounders, the findings were no longer statistically significant (aOR:0.72,95%CI: 0.49,1.06,p = 0.46). No significant unadjusted or adjusted associations emerged in any other ASQ-3 domain.

conclusionThere was no significant association between IIV3 exposure during pregnancy and 6-month infant development. Studies of IIV3 during pregnancy to assess longer-term developmental outcomes are indicated.

Indexed as

Child DevelopmentInfluenza, HumanAdultFemaleHumansInfantInfant, NewbornInfluenza VaccinesMalePregnancyPregnancy Complications, InfectiousPremature BirthProspective StudiesVaccines, InactivatedInfluenza VaccinesVaccines, InactivatedAges and Stages (ASQ)Infant developmentPregnancyTrivalent inactivated influenza vaccine (IIV3)

Identifiers

PMID32033850
PMCPMC7309563
OpenAlexW3004972060

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.